Comparison between Nuvoco Vistas IPO and Tatva Chintan Pharma Chem IPO.
Nuvoco Vistas IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Tatva Chintan Pharma Chem IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Nuvoco Vistas IPO is up to ₹5,000.00 Cr whereas the issue size of the Tatva Chintan Pharma Chem IPO is up to ₹500.00 Cr. The final issue price of Nuvoco Vistas IPO is ₹570.00 per share and of Tatva Chintan Pharma Chem IPO is ₹1,083.00 per share.
| Nuvoco Vistas IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹560.00 per share | ₹1,073.00 per share |
| Issue Price (Upper) | ₹570.00 per share | ₹1,083.00 per share |
| Issue Price (Final) | ₹570.00 per share | ₹1,083.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 26 shares | 13 shares |
| Fresh Issue Size | 2,63,15,789 shares | 20,77,562 shares |
| Fresh Issue Size (Amount) | up to ₹1,500.00 Cr | up to ₹225.00 Cr |
| OFS Issue Size | 6,14,03,508 shares | 25,39,242 shares |
| OFS Issue Size (Amount) | up to ₹3,500.00 Cr | up to ₹275.00 Cr |
| Issue Size Total | 8,77,19,297 shares | 46,16,804 shares |
| Issue Size Total (Amount) | up to ₹5,000.00 Cr | up to ₹500.00 Cr |
Nuvoco Vistas IPO opens on Aug 09, 2021, while Tatva Chintan Pharma Chem IPO opens on Jul 16, 2021. The closing date of Nuvoco Vistas IPO and Tatva Chintan Pharma Chem IPO is Aug 11, 2021, and Jul 20, 2021, respectively.
| Nuvoco Vistas IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| Anchor Bid Date | Aug 06, 2021 | Jul 15, 2021 |
| Issue Open | Aug 09, 2021 | Jul 16, 2021 |
| Issue Close | Aug 11, 2021 | Jul 20, 2021 |
| Basis Of Allotment (Tentative) | Aug 17, 2021 | Jul 26, 2021 |
| Initiation of Refunds (Tentative) | Aug 18, 2021 | Jul 27, 2021 |
| Credit of Share (Tentative) | Aug 20, 2021 | Jul 28, 2021 |
| Listing date (Tentative) | Aug 23, 2021 | Jul 29, 2021 |
| Anchor Lockin End date 1 | Sep 16, 2021 | Aug 25, 2021 |
| Anchor Lockin End date 2 | Nov 15, 2021 | Oct 24, 2021 |
Nuvoco Vistas IPO P/E ratio is , as compared to Tatva Chintan Pharma Chem IPO P/E ratio of .
| Nuvoco Vistas IPO | Tatva Chintan Pharma Chem IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 95.24 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 71.03 | 79.17 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹20357.90 Cr. | ₹2400.48 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Nuvoco Vistas IPO Retail Individual Investors (RII) are offered 3,07,01,754 shares while in Tatva Chintan Pharma Chem IPO retail investors are offered 3,07,01,754 shares. Qualified Institutional Buyers (QIB) are offered 1,75,43,860 shares in Nuvoco Vistas IPO and 9,23,361 shares in Tatva Chintan Pharma Chem IPO.
| Nuvoco Vistas IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| Anchor Investor Reservation | 2,63,15,788 shares | 13,85,040 shares |
| Market Maker Reservation | ||
| QIB | 1,75,43,860 shares | 9,23,361 shares |
| NII | 1,31,57,895 shares | 6,92,521 shares |
| RII | 3,07,01,754 shares | 16,15,882 shares |
| Employee | ||
| Others | ||
| Total | 8,77,19,297 shares | 46,16,804 shares |
Nuvoco Vistas IPO subscribed 1.71x in total, whereas Tatva Chintan Pharma Chem IPO subscribed 180.36x.
| Nuvoco Vistas IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| QIB (times) | 4.23x | 185.23x |
| NII (times) | 0.66x | 512.22x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.73x | 35.35x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.71x | 180.36x |
